Advertisement

Liver Transplantation for Acetaminophen-Induced Acute Liver Failure: Role of Psychiatric Comorbidity in Listing Decisions and Outcomes

  • Okeefe L. Simmons
  • Caitlyn Meinzer
  • Jody Rule
  • William M. LeeEmail author
  • for the Acute Liver Failure Study Group
Original Article
  • 43 Downloads

Abstract

Background

Psychiatric co-morbidities are thought to deter listing of patients with acetaminophen-induced acute liver failure (APAP-ALF) for liver transplantation (LT). We examined the listing process and short-term outcomes via a cohort study of APAP-ALF patients with and without psychiatric comorbidity.

Methods

We analyzed listing determinants, listing rates, and short-term (21-day) outcomes in APAP-ALF patients with and without psychiatric comorbidity (mental illness and/or substance abuse) enrolled in the ALFSG registry between 2000 and 2016.

Results

Of the 910 APAP-ALF patients, 801 (88%) had evidence of psychiatric comorbidity. There was no difference in listing between patients with (169/801, 21%) and without (26/109, 24%) psychiatric comorbidity (p = 0.59). Listed patients in both groups were younger with more severe admission clinical parameters than those not listed. Patients with and without psychiatric comorbidity had similar short-term outcomes: transplant rates among listed patients [57/169 (34%) vs 10/26 (39%), p = 0.80], spontaneous (transplant-free) survival (SS) [544/801 (68%) vs 73/109 (67%), p = 0.93], and overall death [207/801 (26%) vs 26/109 (24%), p = 0.74].

Conclusions

In our study, which is limited by informal psychiatric assessments, psychiatric comorbidity in APAP-ALF patients does not appear to impact listing, or short-term outcomes—SS, LT, or death. Transplant listing decisions primarily appear to be based on clinical severity of disease, rather than concern that APAP-ALF patients’ psychiatric comorbidity will compromise outcomes.

Keywords

Liver failure Acute Liver transplantation Acetaminophen Psychiatric diagnosis 

Abbreviations

ALF

Acute liver failure

ALFSG

Acute Liver Failure Study Group

APAP

Acetaminophen (N-acetyl-p-aminophenol)

ICP

Intracranial pressure monitoring

LT

Liver transplantation

NAC

N-acetylcysteine

SS

Spontaneous survival

Notes

Funding

This study was supported by the National Institute of Diabetes, Digestive and Kidney Diseases, U-01 DK 58369 to UT Southwestern Medical Center. Additional support was provided by the George A Roberts Fund in the Southwestern Medical Foundation.

Compliance with Ethical Standards

Conflict of interest

The authors report no conflicts of interest pertinent to this manuscript.

Supplementary material

10620_2019_5901_MOESM1_ESM.docx (55 kb)
Supplementary material 1 (DOCX 54 kb)

References

  1. 1.
    Reddy KR, Ellerbe C, Schilsky M, et al. Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States. Liver Transpl. 2016;22:505–515.CrossRefGoogle Scholar
  2. 2.
    Bernal W, Cross TJ, Auzinger G, et al. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol. 2009;50:306–313.CrossRefGoogle Scholar
  3. 3.
    Simpson KJ, Bates CM, Henderson NC, et al. The utilization of liver transplantation in the management of acute liver failure: Comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl. 2009;15:600–609.CrossRefGoogle Scholar
  4. 4.
    Reuben A, Tillman H, Fontana RJ, et al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study. Ann Intern Med. 2016;164:724–732.CrossRefGoogle Scholar
  5. 5.
    Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–954.CrossRefGoogle Scholar
  6. 6.
    Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364–1372.CrossRefGoogle Scholar
  7. 7.
    Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med. 1997;337:1112–1117.CrossRefGoogle Scholar
  8. 8.
    Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol. 2016;4:131–142.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Koch DG, Tillman H, Durkalski V, Lee WM, Reuben A. Development of a model to predict transplant-free survival of patients with acute liver failure. Clin Gastroenterol Hepatol. 2016;14:1199–1206.CrossRefGoogle Scholar
  10. 10.
    Pezzia C, Sanders C, Welch S, Bowling A, Lee WM, Acute Liver Failure Study Group. Psychosocial and behavioral factors in acetaminophen-related acute liver failure and liver injury. J Psychosom Res.. 2017;101:51–57.CrossRefGoogle Scholar
  11. 11.
    Randesi M, Levran O, Correa da Rosa J, et al. Association of variants of arginine vasopressin and arginine vasopressin receptor 1A with severe acetaminophen liver injury. Cell Mol Gastroenterol Hepatol.. 2017;3:500–505.CrossRefGoogle Scholar
  12. 12.
    Price A, Whitwell S, Henderson M. Impact of psychotic disorder on transplant eligibility and outcomes. Curr Opin Organ Transpl. 2014;19:196–200.CrossRefGoogle Scholar
  13. 13.
    Corbett C, Armstrong MJ, Parker R, Webb K, Neuberger JM. Mental health disorders and solid-organ transplant recipients. Transplantation. 2013;96:593–600.CrossRefGoogle Scholar
  14. 14.
    Parker R, Armstrong MJ, Corbett C, Day EJ, Neuberger JM. Alcohol and substance abuse in solid-organ transplant recipients. Transplantation. 2013;96:1015–1024.CrossRefGoogle Scholar
  15. 15.
    Fontana RJ, Ellerbe C, Durkalski VE, et al. Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicenter study. Liver Int. 2014;35:370–380.CrossRefGoogle Scholar
  16. 16.
    Rodrigue JR, Hanto DW, Curry MP. Substance abuse treatment and its association with relapse to alcohol use after liver transplantation. Liver Transpl.. 2013;19:1387–1395.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Digestive and Liver Diseases, Department of Internal MedicineUniversity of Texas Southwestern Medical Center at DallasDallasUSA
  2. 2.Department of Public Health SciencesMedical University of South CarolinaCharlestonUSA
  3. 3.Division of Gastrointestinal and Liver DiseasesLos Angeles County + University of Southern California Medical CenterLos AngelesUSA

Personalised recommendations